add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers
 

Kara L. Mungovan

Partner, Tax

Kara L. Mungovan is a partner in Cravath’s Tax Department. Her practice focuses on advising clients on the tax aspects of complex mergers and acquisitions, capital markets transactions and bank financings, both domestically and internationally.

Ms. Mungovan’s clients have included Altra, Anheuser‑Busch InBev, Avon, AXA, Banco Santander, Cigna, Conduent, Crown Castle, Eurazeo, GKN, Hertz, IBM, JBS, Johnson & Johnson, Lazard, Linde, Martin Marietta, Mylan, Peabody Energy, Shire, Stanley Black & Decker, Time Warner, US Foods, Weyerhaeuser, Xerox and Zale.

Ms. Mungovan’s recent transactions include representing:

  • Occidental Petroleum in its $57 billion acquisition of Anadarko, topping Anadarko’s original agreement with Chevron, and the contingent pending $8.8 billion sale of Anadarko’s African assets to Total and $10 billion investment by Berkshire Hathaway;
  • Peabody Energy in its pending multibillion-dollar joint venture with Arch Coal;
  • Deutsche Börse in its $850 million acquisition of Axioma, which was combined with Deutsche Börse’s index businesses valued at €2.6 billion, and its partnership with General Atlantic;
  • US Foods in its $1.8 billion acquisition of SGA Food Group;
  • Stanley Black & Decker in its investment in MTD Products, its acquisition of the Craftsman brand from Sears Holdings and in its $1.95 billion acquisition of the Tools business of Newell Brands;
  • Conduent in the sale of its commercial vehicle operations business to Alinda Capital Partners and the sale of its U.S.‑based human resource consulting and actuarial business to H.I.G. Capital;
  • Mylan in its acquisition of global marketing rights to GA Depot through an investment in and partnership with Mapi Pharma; its $9.9 billion acquisition of Meda; its $750 million acquisition, through its Indian subsidiary Mylan Laboratories Limited, of certain female healthcare businesses from Famy Care; and its $5.6 billion inversion acquisition of Abbott’s non‑U.S. developed markets specialty and branded generics business;
  • GKN in the £8.1 billion unsolicited offer from Melrose and the proposed $6.1 billion combination of its Driveline business and Dana;
  • Altra in its $3 billion combination with four operating companies from Fortive’s Automation and Specialty platform;
  • AXA in its $15.3 billion acquisition of XL Group;
  • Linde in its $70 billion merger of equals with Praxair;
  • Eurazeo in its majority investment in WorldStrides;
  • JBS in its $1.3 billion sale of Moy Park to Pilgrim’s Pride;
  • Banco Santander in its acquisition of the on‑shore consumer credit card and consumer brokerage and retail banking businesses of Citigroup in Argentina;
  • Time Warner in its investment in Hulu and its spin‑off of Time Inc.;
  • Shire in its $32 billion combination with Baxalta;
  • Anheuser‑Busch InBev in its $123 billion acquisition of SABMiller; the $12 billion sale of SABMiller’s U.S. and global Miller branded businesses to Molson Coors; and an asset swap with Ambev in which AB InBev transferred SABMiller’s Panamanian business to Ambev and Ambev transferred its business in Colombia, Peru and Ecuador to AB InBev;
  • Xerox in its spin‑off of Conduent, its Business Process Outsourcing company;
  • Avon in the sale of 80% of its North America business to Cerberus Capital Management and in the PIPE investment by Cerberus in Avon’s international business;
  • IBM in its acquisition of Cleversafe and the $850 million sale of its Retail Store Solutions business;
  • Cigna in its proposed $54.2 billion merger with Anthem;
  • Mylan in the arrangement of a $1.6 billion delayed‑draw term loan credit facility;
  • Crown Castle in the $1.6 billion sale of CCAL, its Australian subsidiary, to a consortium of investors led by Macquarie Infrastructure and Real Assets;
  • Covance in its $6.2 billion sale to LabCorp;
  • Lazard in its $400 million registered senior debt offering; and
  • The Cutrale Group and the Safra Group in their $1.3 billion acquisition of Chiquita.

In 2018 and 2019, Ms. Mungovan was named a “Next Generation Lawyer” in international tax by The Legal 500. She received Euromoney Legal Media Group’s Americas Women in Business Law Award for “Rising Star: Tax” in 2018. Ms. Mungovan was also named a “Rising Star” by Law360 in 2018, recognizing her as one of five outstanding tax lawyers in the nation under the age of 40. She is a member of the Executive Committee of the New York State Bar Association Tax Section and is also a member of the New York Tax Forum.

Ms. Mungovan is from Toronto, Ontario. She received an A.B. magna cum laude in 2004 from Harvard College and a J.D. in 2008 from Harvard Law School, where she was a senior editor of the Negotiation Law Review and a member of the Harvard Defenders. Ms. Mungovan joined Cravath in 2008 and became a partner in 2017.

Ms. Mungovan can be reached by phone at +1‑212‑474‑1954 or by email at kmungovan@cravath.com.

Ms. Mungovan is admitted only in New York.

Contact
+1 (212) 474-1954
+1 (212) 474-3700